We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Amicas (MM) | NASDAQ:AMCS | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.04 | 0 | 01:00:00 |
From Jun 2019 to Jun 2024
Amicas Inc.'s (AMCS) board has deemed a $224.9 million acquisition offer by Merge Healthcare Inc. (MRGE) to be superior to the company's December agreement to be bought by private-equity firm Thoma Bravo LLC.
Amicas said it will terminate its merger agreement if it doesn't reach a better deal with Thoma Bravo in five business days. Shares of Amicas jumped 1.9% to $5.98 in recent premarket action.
Amicas said Merge's offer last week of $6.05 is superior to its December agreement with Thoma Bravo's bid of $5.35. Amicas, which makes radiology, medical-imaging and information-management products, also said it is pushing back its special meeting of shareholders from this coming Thursday to Mar. 16.
Amicas had previously been critical of Merge's offer, at one point calling the bid "highly conditional." But Merge, which develops software products that automate health-care data, later said the bid was fully financed and backed by firms including Morgan Stanley (MS).
Shares of Merge closed Friday at $2.15 and were inactive premarket.
-By Nathan Becker, Dow Jones Newswires; 212-416-2855; nathan.becker@dowjones.com
1 Year Amicas Chart |
1 Month Amicas Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
